InvisiShield and Gladstone partner to develop intranasal preventatives
Pharmaceutical Technology
MARCH 21, 2023
Scientists at Gladstone Institutes will be responsible for carrying out preclinical studies to assess the efficacy and safety of the product. Under the partnership terms, InvisiShield will offer technical support, as well as funding to develop the intranasal preventatives.
Let's personalize your content